Table 2

Overview of study visits, including screening, baseline measurements, after-treatment measurements and follow-up measurements

	Screening and baseline visit	Month						Follow-up 6th month
	Screening and baseline visit	1st	2nd	3rd	4th	5th	6th	Follow-up 6th month
Body composition (weight, height, waist circumference, hip circumference)	√	√	√	√	√	√	√	√
Menstrual cycle diary	√	√	√	√	√	√	√	√
Fasting blood samples for Apoa1, ApoB, TC, TG, C peptide, HbA1c	√						√	√
Fasting blood samples for FSH, LH, SHBG, T, E2, P, DHEAS	√						√	√
Transvaginal ultrasound	√						√	√
Questionnaire	√						√	√
FG/acne	√	√	√	√	√	√	√	√
OGTT	√			√			√	√

Months indicate when each specific measurement takes place.
Apoa1, apolipoprotein A1; ApoB, apolipoprotein B; DHEAS, dehydroepiandrosterone sulfate; E2, estradiol; FG, Ferriman-Gallwey score; FSH, follicle-stimulating hormone; HbA1c, glycated haemoglobin; LH, luteinising hormone; OGTT, oral glucose tolerance test; SHBG, sex hormone-binding globulin; T, total testosterone; TC, total cholesterol; TG, triglyceride.